High-Tech Gründerfonds and Russian Government-backed Maxwell Biotech Venture Fund have invested in a joint project to develop a drug aimed at the treatment of chronic hepatitis B and D.
Around £500,000 of the capital was raised from 866 new investors in Seedrs' network
Deal marks Klingel's third add-on under IK ownership, as well as SHS's third exit of 2020
Company plans to use the fresh capital to scale up its teams and further expand internationally
Livingbridge has invested in several recruitment businesses, including Armstrong Craven and Staffline